About Bolder Science

Our mission is to provide healthcare professionals with unbiased clinical research information, easily.

Currently, you can access the following clinical trials being conducted worldwide:

342,868 studies
in
216 countries
Clinical trial information and results are updated daily from ClinicalTrials.gov. The latest data update was conducted on 08/04/2020.
This website is for US healthcare professionals

Log In to Bolder Science

or

Don't have an account? Sign Up

Please enter your email address.

You will receive a link to create a new password via email.

Log In

Create an Account

or
(optional) ?

Welcome, !

Please complete the following 4 questions to ensure you receive the information that best suits your needs.

Clinical Trials of Interest

When I’m looking for information on clinical trials, I usually am interested in...

finding clinical trials in which to enroll my patients

Rarely Often

finding newly launched clinical trials (for all phases)

Rarely Often

updates on status changes for clinical trials

Rarely Often

pipeline molecules

Rarely Often

Drug Interventions

Enter up to 3 drug interventions you are currently interested in:

Clinical trial information and results are updated daily from ClinicalTrials.gov. The latest data update was conducted on 08/04/2020.
  • DNA Methylation

    The safety and efficacy of the agents and/or uses under investigation have not been established. There is no guarantee that the agents will receive health authority approval or become commercially available in any country for the uses being investigated.

     

    DNA methylation is a modification of cytosine nucleotides catalyzed by DNA methyltransferases.1 This process is important for genomic stability and epigenetic gene silencing in normal cells as well as cellular differentiation during development.2,3 Methylation occurs at CpG dinucleotides, which are often enriched at promoter regions of genes.2,4 In normal tissues, promoter regions are usually unmethylated. Aberrant DNA hypermethylation contributes to gene silencing, including that of tumor suppressor genes, which may promote development and progression of certain cancers.4-9 Aberrant DNA methylation has been observed in correlative studies in a number of malignancies, including myelodysplastic syndromes (MDS), acute myeloid leukemia (AML), breast cancer, and lung cancer.6-11

    As the roles of epigenetic modifications in various malignancies are dissected, epigenetic modifying therapies may increasingly play a role in the treatment of cancer.12

    mRNA, messenger RNA.

    View Related Molecules

    References

    1. Santini V. Expert Rev Hematol. 2009;2:121-127. PMID: 21083445
    2. Santini V, et al. Ann Intern Med. 2001;134:573-586. PMID: 11281740
    3. Karpf AR, Matsui S. Cancer Res. 2005;65:8635-8639. PMID: 16204030
    4. Esteller M. N Engl J Med. 2008;358:1148-1159. PMID: 18337604
    5. Gronbaek K, et al. APMIS. 2007;115:1039-1059. PMID: 18042143
    6. Figueroa ME, et al. Blood. 2009;114:3448-3458. PMID: 19652201
    7. Aggerholm A, et al. Eur J Haematol. 2006;76:23-32. PMID: 16343268
    8. Jiang Y, et al. Blood. 2009;113:1315-1325. PMID: 18832655
    9. Melki JR, et al. Cancer Res. 1999;59:3730-3740. PMID: 10446989
    10. Avraham A, et al. PLoS ONE. 2014;9:e91805. PMID: 24651077
    11. Shames DS, et al. PLoS Med. 2006;3:e486. PMID: 17194187
    12. Dawson MA, Kouzarides T. Cell. 2012;150:12-27. PMID: 22770212